DSMFF Stock Chart & Stats
$95.64
$0.00(0.00%)
At close: 4:00 PM EDT
$95.64
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$61.05 - $111.43
Previous CloseN/A
Volume32.00
Average Volume (3M)N/A
Market Cap
$26.02B
Enterprise Value$25.37K
Total Cash (Recent Filing)$2.31B
Total Debt (Recent Filing)$6.76B
Price to Earnings (P/E)―
Beta0.74
Next Earnings
Feb 18, 2027EPS Estimate
1.71Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.82
Shares Outstanding253,626,950
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)0.98
Price to Sales (P/S)1.97
P/FCF Ratio28.57
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$105.44Price Target Upside10.24% Upside
Rating ConsensusHold
Number of Analyst Covering9
EPS Forecast (FY)4.33
Revenue Forecast (FY)$10.81B
Bulls Say, Bears Say
Bulls Say
Revenue RecoveryThe rebound indicates renewed demand or improved execution across the portfolio, giving the company a stronger base for the next several months. Continued growth could improve operating leverage and support investment in differentiated solutions.
Improved Gross MarginHigher gross margin suggests better pricing, product mix, or cost control at the portfolio level. If sustained, this improvement can strengthen resilience against input-cost pressure and provide greater capacity to fund innovation.
Positive Cash GenerationPositive operating and free cash flow provides internal funding for capital investment, research, and debt service despite reported losses. This supports financial flexibility while management works to restore sustainable profitability.
Bears Say
Persistent Net LossesSustained net losses weaken confidence that revenue and gross-margin improvements are translating into durable shareholder returns. They can also constrain reinvestment capacity and increase reliance on operational recovery to support the business.
Volatile Operating ProfitabilityThe decline in operating margin, alongside a shift from prior profits to recent losses, signals limited earnings durability. Persistent volatility could make planning, investment decisions, and the conversion of sales growth into profit less reliable.
Rising LeverageLeverage remains moderate and equity provides a cushion, but the upward trend increases financial obligations while profitability is weak. Debt coverage should be monitored because prolonged losses could reduce flexibility for investment or restructuring.
DSM-Firmenich AG News
DSMFF FAQ
What was DSM-Firmenich AG’s price range in the past 12 months?
DSM-Firmenich AG lowest stock price was $61.05 and its highest was $111.43 in the past 12 months.
What is DSM-Firmenich AG’s market cap?
DSM-Firmenich AG’s market cap is $26.02B.
When is DSM-Firmenich AG’s upcoming earnings report date?
DSM-Firmenich AG’s upcoming earnings report date is Feb 18, 2027 which is in 174 days.
How were DSM-Firmenich AG’s earnings last quarter?
DSM-Firmenich AG released its earnings results on Jul 30, 2026. The company reported $1.015 earnings per share for the quarter, missing the consensus estimate of $1.03 by -$0.015.
Is DSM-Firmenich AG overvalued?
According to Wall Street analysts DSM-Firmenich AG’s price is currently Undervalued.
Does DSM-Firmenich AG pay dividends?
DSM-Firmenich AG does not currently pay dividends.
What is DSM-Firmenich AG’s EPS estimate?
DSM-Firmenich AG’s EPS estimate is 1.71.
How many shares outstanding does DSM-Firmenich AG have?
DSM-Firmenich AG has 253,626,950 shares outstanding.
What happened to DSM-Firmenich AG’s price movement after its last earnings report?
DSM-Firmenich AG reported an EPS of $1.015 in its last earnings report, missing expectations of $1.03. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of DSM-Firmenich AG?
Currently, no hedge funds are holding shares in DSMFF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
DSM-Firmenich AG
DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. The Animal Nutrition & Health segment offers animal proteins, vitamins, performance solutions, and data-driven precision services. The company was founded in 1902 and is based in Kaiseraugst, Switzerland.
DSMFF Stock 12 Month Forecast
Average Price Target
$105.44
▲(10.24% Upside)
Ownership Overview
―
Insiders
11.61% Mutual Funds
0.17% Other Institutional Investors
77.37% Public Companies and
Individual Investors